Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Examining the ethical considerations of offering fertility preservation options to the families of male paediatric oncology patients
EF 2013-14
Résumé
Provide a summary and a title for your project in language clear to members of the general public. These may be used by the granting agencies to inform the public and Canadian Parliament about the valuable research supported through public funds.
Fertility preservation (FP) among children diagnosed with cancer is associated with ethical and logistical challenges. FP for pre-pubertal boys is currently considered experimental and involves the procurement and cryopreservation of testicular tissue (TTCP) obtained through surgical biopsy. Due to the recent advancements in innovative FP technology and the likelihood that this technology will soon be available for use by prepubescent boys, there are institutions in the United States and in Europe, which offer TTCP for pre-pubescent boys in anticipation of technological advancements. In Canada, however, the climate for similar activity remains relatively under-developed. Due to the specific phrasing of the Assisted Human Reproduction Act, which prohibits the collection of testicular tissue for research for any individual less than 18 years of age, researchers cannot work to develop TTCP or related technology with human tissue. However, once TTCP is developed outside of Canada and there is sufficient evidence to support its use and implementation, clinicians may be able to legally employ the technology in Canada. Even though clinicians and researchers in Canada cannot currently work to advance the technology themselves, they could still offer testicular biopsy to prepubescent cancer patients and their families at this time with the hope that the technology will be accessible in Canada in the near future. Since clinicians are moving towards offering FP options to young boys in Canada, scholars have started to debate important moral and lawful considerations around such procedures. This project seeks to explore how experimental FP technology for male pre-pubertal cancer patients can be applied within a Canadian context and aims to examine the ethical considerations of offering fertility preservation options to the families of young boys with cancer in order to better inform Canadian health policy guidelines.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311675
Name
Roher Sophie I
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Examining the ethical considerations of offering fertility preservation options to the families of male paediatric oncology patients
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioethics; Canada; Decision-Making Factors; Ethical Considerations; Fertility Preservation; Health Policy; Male Paediatric Oncology; Oncofertility; Qualitative Analysis; Testicular Tissue Cyropreservation
Abstract
Provide a summary and a title for your project in language clear to members of the general public. These may be used by the granting agencies to inform the public and Canadian Parliament about the valuable research supported through public funds.
Fertility preservation (FP) among children diagnosed with cancer is associated with ethical and logistical challenges. FP for pre-pubertal boys is currently considered experimental and involves the procurement and cryopreservation of testicular tissue (TTCP) obtained through surgical biopsy. Due to the recent advancements in innovative FP technology and the likelihood that this technology will soon be available for use by prepubescent boys, there are institutions in the United States and in Europe, which offer TTCP for pre-pubescent boys in anticipation of technological advancements. In Canada, however, the climate for similar activity remains relatively under-developed. Due to the specific phrasing of the Assisted Human Reproduction Act, which prohibits the collection of testicular tissue for research for any individual less than 18 years of age, researchers cannot work to develop TTCP or related technology with human tissue. However, once TTCP is developed outside of Canada and there is sufficient evidence to support its use and implementation, clinicians may be able to legally employ the technology in Canada. Even though clinicians and researchers in Canada cannot currently work to advance the technology themselves, they could still offer testicular biopsy to prepubescent cancer patients and their families at this time with the hope that the technology will be accessible in Canada in the near future. Since clinicians are moving towards offering FP options to young boys in Canada, scholars have started to debate important moral and lawful considerations around such procedures. This project seeks to explore how experimental FP technology for male pre-pubertal cancer patients can be applied within a Canadian context and aims to examine the ethical considerations of offering fertility preservation options to the families of young boys with cancer in order to better inform Canadian health policy guidelines.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Roher, Sophie I
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~